Advanced Endo-therapeutic Procedure : Registry-based Observational Study
Launched by CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL (CHUM) · Oct 3, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at advanced endoscopic procedures, which are special techniques used to treat conditions affecting the digestive system, such as Zenker diverticulum, colon polyps, and colorectal cancer. The goal is to gather information about these procedures to improve their availability and effectiveness in Montreal and Quebec. The trial is currently recruiting participants who are at least 18 years old and will be undergoing one of these advanced treatments.
To join the study, participants need to be able to understand the trial and provide their consent. However, individuals who have certain health issues, such as bleeding disorders or are in poor overall health, cannot participate. If you decide to take part, you can expect to receive standard care during your procedure, and you will be helping researchers learn more about these important treatments for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>18 years
- • Presenting for an elective advanced therapeutic endoscopy (ESD, EMR, advanced polypectomy, POEM or Zenker treatment)
- • Signed informed consent form
- Exclusion Criteria:
- • Patients that are not capable understanding the trial and patients without consent.
- • Patients with coagulopathy
- • Patient with poor general health defined as an American Society of Anesthesiologists class greater than three
- • Pregnancy
About Centre Hospitalier De L'université De Montréal (Chum)
The Centre Hospitalier de l'Université de Montréal (CHUM) is a leading academic health institution in Canada, dedicated to advancing patient care through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHUM is committed to leveraging its multidisciplinary expertise and state-of-the-art facilities to facilitate groundbreaking studies that enhance medical knowledge and improve health outcomes. Collaborating with a network of healthcare professionals and researchers, CHUM fosters a rigorous research environment that prioritizes patient safety, ethical standards, and scientific integrity, positioning itself at the forefront of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montréal, Quebec, Canada
Montréal, Quebec, Canada
Patients applied
Trial Officials
Daniel von Renteln, MD,PhD
Principal Investigator
Centre Hospitalier Universitaire de Montréal (CHUM)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials